Ablating UNG activity in a mouse model inhibits colorectal cancer growth by increasing tumor immunogenicity

Uracil DNA glycosylase (UNG) excises uracil and 5-fluorouracil bases from DNA and is implicated in fluorodeoxyuridine (FdU) resistance. Here we explore the effects of inhibiting UNG activity, or depleting the UNG protein, in 2 mouse syngeneic models for colorectal cancer. Overexpressing the small UN...

Full description

Bibliographic Details
Published in:	JCI Insight
Main Authors:	Eric S. Christenson, Brandon E. Smith, Thanh J. Nguyen, Alens Valentin, Soren Charmsaz, Nicole E. Gross, Sarah M. Shin, Alexei Hernandez, Won Jin Ho, Srinivasan Yegnasubramanian, James T. Stivers
Format:	Article
Language:	English
Published:	American Society for Clinical investigation 2025-08-01
Subjects:	Genetics Immunology Oncology
Online Access:	https://doi.org/10.1172/jci.insight.184435

Similar Items

Integrated T cell cytometry metrics for immune-monitoring applications in immunotherapy clinical trials
by: Dimitrios N. Sidiropoulos, et al.
Published: (2022-10-01)

Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinoma
by: Nicole E. Gross, et al.
Published: (2024-09-01)

Role of in silico structural modeling in predicting immunogenic neoepitopes for cancer vaccine development
by: Neeha Zaidi, et al.
Published: (2020-09-01)

Co-targeting TGF-β and PD-L1 sensitizes triple-negative breast cancer to experimental immunogenic cisplatin-eribulin chemotherapy doublet
by: Laura Kalfeist, et al.
Published: (2025-07-01)

Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
by: Divya Nagarajan, et al.
Published: (2024-11-01)

Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma
by: Shin Kobayashi, et al.
Published: (2023-08-01)

CD4 T cell–activating neoantigens enhance personalized cancer vaccine efficacy
by: Amanda L. Huff, et al.
Published: (2023-12-01)

Inhibition of histone methyltransferase EZH2 for immune interception of colorectal cancer in Lynch syndrome
by: Charles M. Bowen, et al.
Published: (2025-03-01)

An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment
by: Bing Yang, et al.
Published: (2022-03-01)

Cxcr3 promotes protection from colorectal cancer liver metastasis by driving NK cell infiltration and plasticity
by: Eleonora Russo, et al.
Published: (2025-06-01)

Intraperitoneal injection of class A TLR9 agonist enhances anti–PD-1 immunotherapy in colorectal peritoneal metastases
by: Ting Jiang, et al.
Published: (2022-10-01)

Targeting heterogeneous tumor microenvironments in pancreatic cancer mouse models of metastasis by TGF-β depletion
by: Sophia Y. Chen, et al.
Published: (2024-11-01)

Gut microbial metabolite 4-hydroxybenzeneacetic acid drives colorectal cancer progression via accumulation of immunosuppressive PMN-MDSCs
by: Qing Liao, et al.
Published: (2025-06-01)

Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell– and CXCR3-dependent manner
by: Michael Brandon Ware, et al.
Published: (2023-04-01)

Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4+ T cells
by: Spencer E. Brightman, et al.
Published: (2023-01-01)

Unique macrophage phenotypes activated by BMP signaling in breast cancer bone metastases
by: Claire L. Ihle, et al.
Published: (2024-01-01)

IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models
by: Janneke E. Jaspers, et al.
Published: (2023-05-01)

Tumor microenvironments with an active type I IFN response are sensitive to inhibitors of heme degradation
by: Dominika Sosnowska, et al.
Published: (2025-08-01)

Dormant tumors circumvent tumor-specific adaptive immunity by establishing a Treg-dominated niche via DKK3
by: Timothy N. Trotter, et al.
Published: (2023-11-01)

Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomas
by: Chang Su, et al.
Published: (2024-07-01)

Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma
by: Joris L. Vos, et al.
Published: (2024-11-01)

Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer
by: Max Heiduk, et al.
Published: (2022-11-01)

PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
by: Tae Kon Kim, et al.
Published: (2024-02-01)

Highly multiplexed imaging reveals prognostic immune and stromal spatial biomarkers in breast cancer
by: Jennifer R. Eng, et al.
Published: (2025-02-01)

Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti–CTLA-4 in renal cell carcinoma
by: David A. Schoenfeld, et al.
Published: (2025-01-01)

An immunosuppressed microenvironment distinguishes lateral ventricle–contacting glioblastomas
by: Todd Bartkowiak, et al.
Published: (2023-06-01)

Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer
by: Colt A. Egelston, et al.
Published: (2022-02-01)

Pivotal roles for cancer cell–intrinsic mPGES-1 and autocrine EP4 signaling in suppressing antitumor immunity
by: Nune Markosyan, et al.
Published: (2024-11-01)

Autonomous IL-36R signaling in neutrophils activates potent antitumor effector functions
by: Sumedha Roy, et al.
Published: (2023-06-01)

YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production
by: Chuangyu Wen, et al.
Published: (2024-12-01)

BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia
by: Audrey L. Smith, et al.
Published: (2024-05-01)

MHC-related protein 1–restricted recognition of cancer via a semi-invariant TCR-α chain
by: Garry Dolton, et al.
Published: (2025-01-01)

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer
by: Brad H. Nelson, et al.
Published: (2024-12-01)

Tumor cell–derived spermidine promotes a protumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition
by: Kristen E. Kay, et al.
Published: (2025-01-01)

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
by: Virginia Laspidea, et al.
Published: (2022-04-01)

Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression
by: Hinda Najem, et al.
Published: (2022-05-01)

Human NLRC4 expression promotes cancer survival and associates with type I interferon signaling and immune infiltration
by: Charlotte Domblides, et al.
Published: (2024-06-01)

B cell–based therapy produces antibodies that inhibit glioblastoma growth
by: Si Wang, et al.
Published: (2024-10-01)

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer
by: Sharon L. Freshour, et al.
Published: (2023-10-01)

Epigenetic therapy sensitizes anti–PD-1 refractory head and neck cancers to immunotherapy rechallenge
by: Tingting Qin, et al.
Published: (2025-03-01)